Objectives The sensitivity of molecular and serological methods for COVID-19 testing in an
epidemiological setting is not well described. The aim of the study was to determine the …

Pan-immunoglobulin assays can simultaneously detect IgG, IgM and IgA directed against
the receptor binding domain (RBD) of the S1 subunit of the spike protein (S) of severe acute …

Objectives We investigated machinelearningbased identification of presymptomatic COVID-19
and detection of infection-related changes in physiology using a wearable device. Design …

Background and aims The potential of disease-modifying therapies for Alzheimer’s disease
has greatly stimulated interest in the development of minimally invasive testing for early …

Several tests based on chemiluminescence immunoassay techniques have become available
to test for SARS-CoV-2 antibodies. There is currently insufficient data on serology assay …

While lateral flow test formats can be utilized with whole blood and low sample volumes,
their diagnostic characteristics are inferior to immunoassays based on chemiluminescence …

Knowledge of the sensitivities of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
antibody tests beyond 35 days after the clinical onset of COVID-19 is insufficient. We …

It is unknown whether neurological symptoms are associated with brain injury after SARS-CoV-2
infections and whether brain injury and related symptoms also emerge in Long-COVID …

Considering sex as a biological variable in modern digital health solutions, we investigated
sex-specific differences in the trajectory of four physiological parameters across a COVID-19 …

Background: Omega-3 fatty acids are associated with a lower risk of cardiovascular disease
(CVD) and with beneficial effects on CV risk factors. The albumin-creatinine ratio (ACR) is a …